Cyberonics Inc. to Present at Sidoti & Company 14th Annual Emerging Growth New York Institutional Investor Conference

HOUSTON, March 18, 2010 /PRNewswire via COMTEX/ -- Cyberonics, Inc. /quotes/comstock/15*!cybx/quotes/nls/cybx (CYBX 18.70, -0.03, -0.16%) today announced that Gregory H. Browne, Cyberonics' Chief Financial Officer, will present at the Sidoti & Company 14th Annual Emerging Growth New York Institutional Investor Conference in New York on Tuesday, March 23, 2010 at 10:00 AM EDT. Presentation slides will be available on-line at www.cyberonics.com by 8:00 AM EDT on Tuesday, March 23, 2010. The presentation will not be webcast.

About Cyberonics, Inc. and VNS Therapy(R)

Cyberonics, Inc. /quotes/comstock/15*!cybx/quotes/nls/cybx (CYBX 18.70, -0.03, -0.16%) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in approximately 60 countries worldwide, and to date more than 55,000 patients have been implanted with the device.

Additional information on Cyberonics and VNS Therapy is available at www.cyberonics.com.

CONTACT INFORMATION:

Greg Browne, CFO Cyberonics, Inc. 100 Cyberonics Blvd. Houston, TX 77058 Main: (281) 228-7262 Fax: (281) 218-9332 ir@cyberonics.com